These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6190741)

  • 1. Differential recognition of the serologically defined HLA-A2 antigen by allogeneic cytotoxic T cells. II. Definition of three HLA-A2 subtypes by CTLs.
    van der Poel JJ; Pool J; Goulmy E; van Rood JJ
    Immunogenetics; 1983; 17(6):599-608. PubMed ID: 6190741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential recognition of the serologically defined HLA-A2 antigen by allogeneic cytotoxic T cells. I. Population studies.
    Horai S; van der Poel JJ; Goulmy E
    Immunogenetics; 1982; 16(2):135-42. PubMed ID: 6183196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the functional epitopes on different HLA-A2 molecules.
    Goulmy E; van der Poel J; Giphart M; van Rood JJ
    Immunogenetics; 1984; 20(1):13-21. PubMed ID: 6204938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of distinct epitopes on the HLA-A2 antigen by cytotoxic T lymphocytes.
    van der Poel JJ; Pool J; Goulmy E; Giphart MJ; van Rood JJ
    Hum Immunol; 1986 Jul; 16(3):247-58. PubMed ID: 2424874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition of four HLA-A2 subtypes by CML typing and biochemical analysis.
    van der Poel JJ; Mölders H; Thompson A; Ploegh HL
    Immunogenetics; 1983; 17(6):609-21. PubMed ID: 6407985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. Heterogeneity of T cell-restricting determinants associated with the serologically defined HLA-A2 antigen.
    Gaston JS; Rickinson AB; Epstein MA
    J Exp Med; 1983 Aug; 158(2):280-93. PubMed ID: 6193217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of cytotoxic T lymphocytes in HLA-A, -B and -C-identical responder-stimulator pairs. II. New subtypes of HLA-Bw35.
    Breuning MH; Breur BS; Engelsma MY; Goulmy E; Iványi P
    Tissue Antigens; 1984 Aug; 24(2):90-7. PubMed ID: 6208634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.
    Ware CF; Krangel MS; Pious D; Burakoff SJ; Strominger JL
    J Immunol; 1983 Sep; 131(3):1312-7. PubMed ID: 6193184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allospecific T cell recognition of HLA-A2 antigens: evidence for group-specific and subgroup-specific epitopes.
    Wallace LE; Houghton MA; Rickinson AB; Epstein MA; Bradley BA
    Immunogenetics; 1985; 21(3):201-14. PubMed ID: 2580783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell mediated PPD specific cytotoxicity against human monocyte targets: III. Cellular typing with CTLs restricted by class II HLA antigens.
    Hansen PW; Kristensen T
    Tissue Antigens; 1986 Apr; 27(4):227-38. PubMed ID: 2425454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of an HLA-A2 functional variant CLA defined by cytolytic T lymphocytes.
    Ezquerra A; Doménech N; van der Poel J; Strominger JL; Vega MA; López de Castro JA
    J Immunol; 1986 Sep; 137(5):1642-9. PubMed ID: 3489037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of cell-mediated lympholysis (CML) in man.
    Singal DP; Wadia YJ
    Tissue Antigens; 1980 Feb; 15(2):177-88. PubMed ID: 12735318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of B cell-bound HLA-A2 class I monomers to generate high-avidity, allo-restricted CTLs against the leukemia-associated protein Wilms tumor antigen.
    Savage P; Gao L; Vento K; Cowburn P; Man S; Steven N; Ogg G; McMichael A; Epenetos A; Goulmy E; Stauss HJ
    Blood; 2004 Jun; 103(12):4613-5. PubMed ID: 14988155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.
    Darrow TL; Slingluff CL; Seigler HF
    J Immunol; 1989 May; 142(9):3329-35. PubMed ID: 2785141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivity patterns with HLA-A2 variants indicate lack of identity between determinants defined by monoclonal antibodies and cytotoxic-T-cell clones.
    Russo C; Flomenberg N; Dupont B; Ferrone S
    Cell Immunol; 1984 Oct; 88(1):228-32. PubMed ID: 6206957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The recognition of abnormal sex chromosome constitution by HLA-restricted anti-H-Y cytotoxic T cells and antibody.
    Goulmy E; van Leeuwen A; Blokland E; Sachs ES; Geraedts JP
    Immunogenetics; 1983; 17(5):523-31. PubMed ID: 6601615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of the Epstein-Barr virus latent membrane protein 2 antigen-specific cytotoxic T lymphocytes using human leukocyte antigen tetramer-based artificial antigen-presenting cells.
    Lu XL; Liang ZH; Zhang CE; Lu SJ; Weng XF; Wu XW
    Acta Biochim Biophys Sin (Shanghai); 2006 Mar; 38(3):157-63. PubMed ID: 16518539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative structural analysis of HLA-A2 antigens distinguishable by cytotoxic T lymphocytes. II. Variant DK1: evidence for a discrete CTL recognition region.
    Krangel MS; Biddison WE; Strominger JL
    J Immunol; 1983 Apr; 130(4):1856-62. PubMed ID: 6601143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia.
    Molldrem JJ; Lee PP; Wang C; Champlin RE; Davis MM
    Cancer Res; 1999 Jun; 59(11):2675-81. PubMed ID: 10363991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the HLA-A2.2 subtype: T cell evidence for further heterogeneity.
    Gotch FM; Kelly C; Ellis SA; Wallace L; Rickinson AB; van der Poel J; Crumpton MJ; McMichael AJ
    Immunogenetics; 1985; 21(1):11-23. PubMed ID: 2981768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.